Skip to main content
. 2022 Jul 27;14(7):1382–1397. doi: 10.4254/wjh.v14.i7.1382

Figure 5.

Figure 5

Pathologic gene patterns shared in the non-alcoholic fatty liver disease and non-alcoholic steatohepatitis meta-analyeses are highlighted above. This dataset was inputted in clue.io to identify potential drug targets. We found riciribine (an AKT inhibitor) and ZSTK-474 (a PI3K inhibitor) as drugs that best targeted the gene expression above.